Phenol-Soluble Modulin α3 Enhances the Human Neutrophil Lysis Mediated by Panton-Valentine Leukocidin

被引:67
作者
Hongo, Isamu [2 ]
Baba, Tadashi [1 ,2 ]
Oishi, Kanenari [3 ]
Morimoto, Yuh [1 ]
Ito, Teruyo [1 ,2 ]
Hiramatsu, Keiichi [1 ,2 ]
机构
[1] Juntendo Univ, Grad Sch Med, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Infect Control Sci, Tokyo 1138421, Japan
[3] Bacterial Diagnost Prod Dept, Niigata, Japan
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; POLYMORPHONUCLEAR LEUKOCYTES; VIRULENCE DETERMINANTS; GAMMA-HEMOLYSIN; GENES; PURIFICATION; STRAINS; LEUCOCIDIN; INFECTIONS; CLONES;
D O I
10.1086/605332
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Panton-Valentine leukocidin (PVL) has long been considered a critical toxin in severe Staphylococcus aureus infection. PVL presumably breaches the body's defense system by lysing human polymorphonuclear cells (PMNs). Recently, however, bioactive peptides- phenol-soluble modulins (PSMs)-have been proposed as the main player in the lysis of PMNs, rather than PVL. This study aimed to resolve uncertainty concerning the cause of the lysis of human PMNs by using recombinant PVL toxins and PVL-neutralizing monoclonal antibodies. The recombinant PVL toxins showed strong lytic activity against human but not murine neutrophils. Moreover, the lytic activity of culture supernatants of strains USA400 MW2 and USA300 FPR3757 were completely neutralized by anti-PVL monoclonal antibodies. In contrast, phenol-soluble modulin alpha 3-the most potent PSM peptide-failed to lyse human PMNs at the concentrations contained in the culture supernatants. Phenol-soluble modulin alpha 3 did, however, enhance PVL-mediated lysis of human PMNs.
引用
收藏
页码:715 / 723
页数:9
相关论文
共 49 条
[1]  
[Anonymous], 1999, JAMA, V282, P1123
[2]   Genome and virulence determinants of high virulence community-acquired MRSA [J].
Baba, T ;
Takeuchi, F ;
Kuroda, M ;
Yuzawa, H ;
Aoki, K ;
Oguchi, A ;
Nagai, Y ;
Iwama, N ;
Asano, K ;
Naimi, T ;
Kuroda, H ;
Cui, L ;
Yamamoto, K ;
Hiramatsu, K .
LANCET, 2002, 359 (9320) :1819-1827
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice [J].
Brinkman-Vand der Linden, ECM ;
Angata, T ;
Reynolds, SA ;
Powell, LD ;
Hedrick, SM ;
Varki, A .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (12) :4199-4206
[5]   Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus [J].
Diep, BA ;
Carleton, HA ;
Chang, RF ;
Sensabaugh, GF ;
Perdreau-Remington, F .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (11) :1495-1503
[6]   Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus [J].
Diep, BA ;
Gill, SR ;
Chang, RF ;
Phan, TH ;
Chen, JH ;
Davidson, MG ;
Lin, F ;
Lin, J ;
Carleton, HA ;
Mongodin, EF ;
Sensabaugh, GF ;
Perdreau-Remington, F .
LANCET, 2006, 367 (9512) :731-739
[7]   Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin [J].
Diep, BA ;
Sensabaugh, GF ;
Somboona, NS ;
Carleton, HA ;
Perdreau-Remington, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) :2080-2084
[8]   Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis [J].
Diep, Binh An ;
Palazzolo-Ballance, Amy M. ;
Tattevin, Pierre ;
Basuino, Li ;
Braughton, Kevin R. ;
Whitney, Adeline R. ;
Chen, Liang ;
Kreiswirth, Barry N. ;
Otto, Michael ;
DeLeo, Frank R. ;
Chambers, Henry F. .
PLOS ONE, 2008, 3 (09)
[9]   Panton-Valentine leukocidin-producing Staphylococcus aureus responsible for necrotizing pneumonia [J].
Dubrous, P. ;
Cuguillere, A. ;
Gendrot, A. ;
Koeck, J.-L. .
ANNALES DE BIOLOGIE CLINIQUE, 2007, 65 (03) :277-281
[10]   Community-acquired methicillin-resistant Staphylococcus aureus infections in France:: Emergence of a single clone that produces Panton-Valentine leukocidin [J].
Dufour, P ;
Gillet, Y ;
Bes, M ;
Lina, G ;
Vandenesch, F ;
Floret, D ;
Etienne, J ;
Richet, H .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) :819-824